SiDx, Inc.
Biotechnology company · Seattle, Washington, United States
SiDx, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2017.
SiDx at a glance
What does SiDx do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2018 to 2021). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.5 million sold (2017).
Frequently asked questions about SiDx
Where is SiDx headquartered?
SiDx, Inc. is headquartered in Seattle, Washington, United States.
What does SiDx do?
SiDx, Inc. is a biotechnology company.
When was SiDx founded?
The earliest incorporation on record for SiDx, Inc. is in 2017, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences